343 related articles for article (PubMed ID: 19352355)
1. Indian biotechs partner with government.
Jayaraman KS
Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352355
[No Abstract] [Full Text] [Related]
2. Malaysia seeks biotech partners.
Aldridge S
Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352354
[No Abstract] [Full Text] [Related]
3. India's strategy to bridge the public-private divide.
Jayaraman KS
Nat Biotechnol; 2005 May; 23(5):523. PubMed ID: 15942982
[No Abstract] [Full Text] [Related]
4. Singapore R&D and globetrotting.
Lear MJ; Salmons B; Gunzburg WH; Dangerfield JA
Biotechnol J; 2009 Feb; 4(2):179-85. PubMed ID: 19156748
[No Abstract] [Full Text] [Related]
5. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea.
Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY
Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865
[No Abstract] [Full Text] [Related]
6. Antiinfective biotechs face partnering gap.
Sheridan C
Nat Biotechnol; 2005 Feb; 23(2):155-6. PubMed ID: 15696131
[No Abstract] [Full Text] [Related]
7. Biotech parks proliferate, despite concerns over sustainability.
Jia H; Jayaraman KS; Orellana C
Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
[No Abstract] [Full Text] [Related]
8. Indian biotechnology--rapidly evolving and industry led.
Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
[No Abstract] [Full Text] [Related]
9. Earlier stage biotechs attract partners.
Ratner M
Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
[No Abstract] [Full Text] [Related]
10. No-fee university licenses spur biotech partnerships.
Moran N
Nat Biotechnol; 2013 May; 31(5):376. PubMed ID: 23657381
[No Abstract] [Full Text] [Related]
11. France to focus on a few biotech clusters.
Balcon E
Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
[No Abstract] [Full Text] [Related]
12. China moves to reform biotech policies.
Jia H
Nat Biotechnol; 2004 Oct; 22(10):1197. PubMed ID: 15470442
[No Abstract] [Full Text] [Related]
13. Biotechnology in South Africa.
Cloete TE; Nel LH; Theron J
Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
[TBL] [Abstract][Full Text] [Related]
14. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
15. Superscience me!
Nat Biotechnol; 2007 Jun; 25(6):604. PubMed ID: 17557082
[No Abstract] [Full Text] [Related]
16. A principled partnership between academic medicine and industry.
Kirch DG
Medscape J Med; 2008; 10(8):198. PubMed ID: 18924650
[No Abstract] [Full Text] [Related]
17. Medical devices: partnering for success.
Reynolds K
Australas Phys Eng Sci Med; 2009 Dec; 32(4):xi-xii. PubMed ID: 20169834
[No Abstract] [Full Text] [Related]
18. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
Zhang Z; Jia M; Wan D
Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
[TBL] [Abstract][Full Text] [Related]
19. Biotechs follow big pharma lead back into academia.
Kling J
Nat Biotechnol; 2011 Jul; 29(7):555-6. PubMed ID: 21747364
[No Abstract] [Full Text] [Related]
20. Building effective public-private partnerships: experiences and lessons from the African Comprehensive HIV/AIDS Partnerships (ACHAP).
Ramiah I; Reich MR
Soc Sci Med; 2006 Jul; 63(2):397-408. PubMed ID: 16487640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
